已收盘 02-06 16:00:00 美东时间
+8.000
+4.64%
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
9 analysts have expressed a variety of opinions on Herc Holdings (NYSE:HRI) ove...
01-24 03:01
Wells Fargo analyst Jerry Revich maintains Herc Holdings (NYSE:HRI) with a Overweight and raises the price target from $170 to $189.
01-23 22:52
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
Citigroup analyst Kyle Menges maintains Herc Holdings (NYSE:HRI) with a Buy and raises the price target from $170 to $195.
01-14 03:30
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
The latest announcement is out from Herc Holdings ( ($HRI) ). On December 16, 2...
2025-12-17 06:19
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
2025-12-12 10:24
Citigroup analyst Kyle Menges maintains Herc Holdings (NYSE:HRI) with a Buy and raises the price target from $160 to $170.
2025-12-12 05:19